Browse the latest research summaries in the field of urology for spinal cord injury patients and caregivers.
Showing 111-120 of 389 results
The Journal of Spinal Cord Medicine, 2019 • November 1, 2019
This case report describes a 62-year-old man with chronic cervical SCI who experienced autonomic dysreflexia and was successfully treated with an intravesical botulinum toxin injection. The injection ...
KEY FINDING: Intravesical botulinum toxin injection can effectively control symptoms of autonomic dysreflexia in patients with chronic SCI.
The Journal of Spinal Cord Medicine, 2020 • May 1, 2020
The study prospectively evaluated urodynamic changes in individuals with SCI practicing CIC to understand long-term complications despite CIC and compare the urodynamic bladder profile of overactive d...
KEY FINDING: Cystometric capacity and compliance decreased significantly over time, despite regular CIC and antimuscarinic medication use.
The Journal of Spinal Cord Medicine, 2020 • July 1, 2020
This retrospective study compared urodynamic findings in patients with complete and incomplete traumatic spinal cord injuries (SCI). The aim was to determine the importance of urodynamic testing in pa...
KEY FINDING: No statistically significant difference was found in maximum cystometric capacity (MCC) between complete and incomplete SCI patients.
The Journal of Spinal Cord Medicine, 2019 • January 1, 2019
This case report describes the unexpected finding of catheter fragments in the bladder of a spinal cord injured patient using clean intermittent catheterization (CIC). The patient presented with incre...
KEY FINDING: A rare complication of CIC was identified where 'insertion sleeves' from the catheter detached and remained in the bladder.
The Journal of Spinal Cord Medicine, 2020 • January 1, 2020
This report presents two cases of tetraplegic individuals who developed proximal arm weakness temporally related to intradetrusor onabotulinumtoxinA administration without systemic effects. The arm we...
KEY FINDING: Two tetraplegic patients experienced proximal arm weakness following intradetrusor onabotulinumtoxinA administration.
The Journal of Spinal Cord Medicine, 2021 • January 1, 2021
This case report describes a 20-year-old male with a C-5 spinal cord injury who experienced recurrent priapism, characterized by frequent, non-sexual erections. The patient was treated with baclofen, ...
KEY FINDING: Recurrent priapism is a rare condition in patients with spinal cord injury (SCI).
The Journal of Spinal Cord Medicine, 2021 • May 24, 2019
This phase Ia clinical trial assessed the safety and tolerability of a single intravesical instillation of Lactobacillus rhamnosus GG in patients with neuropathic bladder. The study included five chil...
KEY FINDING: Intravesical instillation of Lactobacillus rhamnosus GG was well-tolerated by all patients, with no immediate adverse events.
The Journal of Spinal Cord Medicine, 2020 • January 1, 2020
The goal of this article is to provide guidance for selection of bladder and bowel measures applicable as either primary or ancillary outcomes. Several fundamental assessments share reasonable levels ...
KEY FINDING: Three fundamental measures each for bladder and bowel assessments were identified, centering upon tissue morphology, voiding efficiency/volume, and smooth muscle-mediated pressure studies.
The Journal of Spinal Cord Medicine, 2019 • January 1, 2019
This study describes the development of indicators for sexual health in SCI/D rehabilitation to improve care quality. The indicators focus on structure (HCP training), process (resource introduction),...
KEY FINDING: The structure indicator is the proportion of rehabilitation HCPs who have completed annual preliminary sexual health training.
Therapeutic Advances in Urology, 2019 • June 17, 2019
The study assessed the safety and tolerability of self-administered intravesical LGG® in adults and children with NLUTD due to SCI/D who use intermittent catheterization. Participants self-instilled L...
KEY FINDING: One or two doses of self-instilled intravesical LGG® in response to more cloudy or foul-smelling urine was safe and well tolerated among adults and children with SCI/D who have NLUTD and use IC.